Penn Capital Management Company, LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1158202
PHILADELPHIA, PA
Position in LGND
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$19,057,790
+$368,599 QoQ
Shares Held
95,456
-3.4% QoQ
Ownership
0.476%
of shares outstanding
% of Portfolio
1.49%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Penn Capital Management Company, LLC holds $79,843,281 across 7 Biotechnology names. LGND ranks #2 (23.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
256,767 | $23,720,135 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
This page
|
95,456 | $19,057,790 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
541,960 | $18,003,911 | |
| 4 | SLNO |
Soleno Therapeutics Inc
|
268,785 | $8,998,921 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
333,130 | $7,848,542 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,510 | $1,837,379 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
12,676 | $376,603 |
All Filings in LGND
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,057,790 | 95,456 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $18,689,191 | 98,848 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $19,003,933 | 107,282 | Shares | Sole | 2025-11-24 | |
| 2025-06-30 | $13,685,253 | 120,384 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $12,705,012 | 120,839 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $11,189,674 | 104,430 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,030,819 | 100,218 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||